{"entity":{"type":"insider","cik":"0001932843","url":"/insider/0001932843","json_url":"/insider/0001932843.json","name":"Lazar David E.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":8,"first":"2022-07-08","last":"2025-08-04","span_basis":"filed_date"},"name_variants":[{"name":"Lazar David E.","source":"filing","n_filings":8,"first_seen":"2022-07-08","last_seen":"2025-08-04"}],"transactions":[{"id":4574194,"accession":"0000921895-25-002082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-25-002082","line_url":"/filing/0000921895-25-002082#line-1","is_derivative":false,"issuer_cik":"0001130166","issuer_name":"Cyclacel Pharmaceuticals, Inc.","issuer_ticker":"CYCC","issuer_name_source":null,"issuer_url":"/issuer/0001130166","owner_cik":"0001932843","owner_name":"Lazar David E.","owner_display_name":"Lazar David E.","owner_url":"/insider/0001932843","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6750.0,"shares_display":"6,750","price_per_share":12.36,"price_display":"12.36","price_state":"stated","total_value":83430.0,"total_display":"83,430.00","total_whole":"83,430","shares_owned_after":155838.0,"shares_owned_after_display":"155,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-30","filed_date":"2025-08-04","scope":"insider"},{"id":4657729,"accession":"0000921895-25-000651","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000921895-25-000651","line_url":"/filing/0000921895-25-000651#line-3","is_derivative":false,"issuer_cik":"0001130166","issuer_name":"Cyclacel Pharmaceuticals, Inc.","issuer_ticker":"CYCC","issuer_name_source":null,"issuer_url":"/issuer/0001130166","owner_cik":"0001932843","owner_name":"Lazar David E.","owner_display_name":"Lazar David E.","owner_url":"/insider/0001932843","role":"Officer (Interim CEO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Interim CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":194628820.0,"shares_display":"194,628,820","price_per_share":0.0283,"price_display":"0.03","price_state":"stated","total_value":5507995.606,"total_display":"5,507,995.61","total_whole":"5,507,996","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-26","filed_date":"2025-02-28","scope":"insider"},{"id":2579790,"accession":"0000921895-24-003050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-24-003050","line_url":"/filing/0000921895-24-003050#line-1","is_derivative":false,"issuer_cik":"0001467761","issuer_name":"MINIM, INC.","issuer_ticker":"MINM","issuer_name_source":null,"issuer_url":"/issuer/0001467761","owner_cik":"0001932843","owner_name":"Lazar David E.","owner_display_name":"Lazar David E.","owner_url":"/insider/0001932843","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1456980.0,"shares_display":"1,456,980","price_per_share":0.0343,"price_display":"0.03","price_state":"stated","total_value":49974.414,"total_display":"49,974.41","total_whole":"49,974","shares_owned_after":1481980.0,"shares_owned_after_display":"1,481,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-26","filed_date":"2024-12-31","scope":"insider"},{"id":2765522,"accession":"0000921895-24-002812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-24-002812","line_url":"/filing/0000921895-24-002812#line-2","is_derivative":false,"issuer_cik":"0001843165","issuer_name":"LQR House Inc.","issuer_ticker":"LQR","issuer_name_source":null,"issuer_url":"/issuer/0001843165","owner_cik":"0001932843","owner_name":"Lazar David E.","owner_display_name":"Lazar David E.","owner_url":"/insider/0001932843","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":280000.0,"shares_display":"280,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-25","filed_date":"2024-11-25","scope":"insider"},{"id":2765517,"accession":"0000921895-24-002812","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-24-002812","line_url":"/filing/0000921895-24-002812#line-1","is_derivative":false,"issuer_cik":"0001843165","issuer_name":"LQR House Inc.","issuer_ticker":"LQR","issuer_name_source":null,"issuer_url":"/issuer/0001843165","owner_cik":"0001932843","owner_name":"Lazar David E.","owner_display_name":"Lazar David E.","owner_url":"/insider/0001932843","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":821818.0,"shares_display":"821,818","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":280000.0,"shares_owned_after_display":"280,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-21","filed_date":"2024-11-25","scope":"insider"},{"id":9208993,"accession":"0000921895-23-001593","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-23-001593","line_url":"/filing/0000921895-23-001593","is_derivative":false,"issuer_cik":"0001817604","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"TTNP","issuer_name_source":null,"issuer_url":"/issuer/0001817604","owner_cik":null,"owner_name":"Activist Investing LLC; Lazar David E.","owner_display_name":"Activist Investing LLC","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3747968.0,"shares_display":"3,747,968","price_per_share":1.23,"price_display":"1.23","price_state":"stated","total_value":4610000.64,"total_display":"4,610,000.64","total_whole":"4,610,001","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-28","scope":"insider","n_lines":2},{"id":8063665,"accession":"0000921895-23-001569","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-23-001569","line_url":"/filing/0000921895-23-001569","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"TTNP","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":null,"owner_name":"Activist Investing LLC; Lazar David E.","owner_display_name":"Activist Investing LLC","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3747968.0,"shares_display":"3,747,968","price_per_share":1.23,"price_display":"1.23","price_state":"stated","total_value":4610000.64,"total_display":"4,610,000.64","total_whole":"4,610,001","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider","n_lines":2},{"id":8010924,"accession":"0000921895-23-000200","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-23-000200","line_url":"/filing/0000921895-23-000200#line-2","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"TTNP","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":null,"owner_name":"Lazar David E.; Activist Investing LLC","owner_display_name":"Lazar David E.","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.0033,"price_display":"1.00","price_state":"stated","total_value":20066.0,"total_display":"20,066.00","total_whole":"20,066","shares_owned_after":3388902.0,"shares_owned_after_display":"3,388,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-25","filed_date":"2023-01-26","scope":"insider"},{"id":8010921,"accession":"0000921895-23-000200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-23-000200","line_url":"/filing/0000921895-23-000200#line-1","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"TTNP","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":null,"owner_name":"Lazar David E.; Activist Investing LLC","owner_display_name":"Lazar David E.","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":37500.0,"shares_display":"37,500","price_per_share":0.9659,"price_display":"0.97","price_state":"stated","total_value":36221.25,"total_display":"36,221.25","total_whole":"36,221","shares_owned_after":3368902.0,"shares_owned_after_display":"3,368,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-26","scope":"insider"},{"id":6465615,"accession":"0001829126-22-014209","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001829126-22-014209","line_url":"/filing/0001829126-22-014209#line-3","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"TTNP","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":null,"owner_name":"Activist Investing LLC; Lazar David E.","owner_display_name":"Activist Investing LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":744294.0,"shares_display":"744,294","price_per_share":0.9929,"price_display":"0.99","price_state":"stated","total_value":739009.5126,"total_display":"739,009.51","total_whole":"739,010","shares_owned_after":3331402.0,"shares_owned_after_display":"3,331,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-07","filed_date":"2022-07-08","scope":"insider"},{"id":6465613,"accession":"0001829126-22-014209","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001829126-22-014209","line_url":"/filing/0001829126-22-014209","is_derivative":false,"issuer_cik":"0000910267","issuer_name":"TITAN PHARMACEUTICALS INC","issuer_ticker":"TTNP","issuer_name_source":null,"issuer_url":"/issuer/0000910267","owner_cik":null,"owner_name":"Activist Investing LLC; Lazar David E.","owner_display_name":"Activist Investing LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1481896.0,"shares_display":"1,481,896","price_per_share":0.7988905747096963,"price_display":"0.80","price_state":"stated","total_value":1183872.7471,"total_display":"1,183,872.75","total_whole":"1,183,873","shares_owned_after":2587108.0,"shares_owned_after_display":"2,587,108","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-06","filed_date":"2022-07-08","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001130166","name":"Cyclacel Pharmaceuticals, Inc.","url":"/issuer/0001130166","role":"Officer (Interim CEO), Ten percent owner","n_filings":2,"first_seen":"2025-02-28","last_seen":"2025-08-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001467761","name":"MINIM, INC.","url":"/issuer/0001467761","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2024-12-31","last_seen":"2024-12-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001843165","name":"LQR House Inc.","url":"/issuer/0001843165","role":"Director, Officer (President)","n_filings":1,"first_seen":"2024-11-25","last_seen":"2024-11-25"},{"type":"issuer","type_label":"ISSUER","cik":"0000910267","name":"TITAN PHARMACEUTICALS INC","url":"/issuer/0000910267","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":4,"first_seen":"2022-07-08","last_seen":"2023-06-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001932843","retrieved_at":"2026-08-24T03:08:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}